nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—HTR1E—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0503	0.0625	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0415	0.0515	CbGpPWpGaD
Ergonovine—HTR1E—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0354	0.0439	CbGpPWpGaD
Ergonovine—HTR1E—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0343	0.0426	CbGpPWpGaD
Ergonovine—HTR1E—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.032	0.0397	CbGpPWpGaD
Ergonovine—HTR1E—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0297	0.0369	CbGpPWpGaD
Ergonovine—HTR1E—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0289	0.0359	CbGpPWpGaD
Ergonovine—HTR1E—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0269	0.0334	CbGpPWpGaD
Ergonovine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0253	0.0314	CbGpPWpGaD
Ergonovine—HTR1E—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0224	0.0278	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0209	0.0259	CbGpPWpGaD
Ergonovine—HTR1E—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0188	0.0234	CbGpPWpGaD
Ergonovine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0178	0.0221	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0177	0.022	CbGpPWpGaD
Ergonovine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0173	0.0215	CbGpPWpGaD
Ergonovine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.0168	0.0209	CbGpPWpGaD
Ergonovine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0161	0.02	CbGpPWpGaD
Ergonovine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0151	0.0188	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.015	0.0186	CbGpPWpGaD
Ergonovine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0147	0.0182	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0145	0.018	CbGpPWpGaD
Ergonovine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0137	0.017	CbGpPWpGaD
Ergonovine—Pergolide—DRD4—Gilles de la Tourette syndrome	0.0136	0.102	CrCbGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0135	0.0168	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0127	0.0158	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0123	0.0153	CbGpPWpGaD
Ergonovine—Lisuride—DRD4—Gilles de la Tourette syndrome	0.0118	0.0887	CrCbGaD
Ergonovine—Pergolide—DRD3—Gilles de la Tourette syndrome	0.0117	0.0882	CrCbGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0115	0.0143	CbGpPWpGaD
Ergonovine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0113	0.014	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD4—Gilles de la Tourette syndrome	0.0109	0.0822	CrCbGaD
Ergonovine—Lisuride—DRD3—Gilles de la Tourette syndrome	0.0102	0.0765	CrCbGaD
Ergonovine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.0096	0.154	CbGeAlD
Ergonovine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00958	0.0119	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00947	0.0118	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD3—Gilles de la Tourette syndrome	0.00942	0.0709	CrCbGaD
Ergonovine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00924	0.149	CbGeAlD
Ergonovine—Pergolide—DRD2—Gilles de la Tourette syndrome	0.00811	0.061	CrCbGaD
Ergonovine—Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.00811	0.061	CrCbGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00805	0.01	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00735	0.00914	CbGpPWpGaD
Ergonovine—HTR1E—brain—Gilles de la Tourette syndrome	0.00734	0.118	CbGeAlD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00714	0.00887	CbGpPWpGaD
Ergonovine—Lisuride—DRD2—Gilles de la Tourette syndrome	0.00704	0.053	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00682	0.00848	CbGpPWpGaD
Ergonovine—Methysergide—HTR2A—Gilles de la Tourette syndrome	0.00677	0.0509	CrCbGaD
Ergonovine—Ergotamine—DRD2—Gilles de la Tourette syndrome	0.00676	0.0509	CrCbGaD
Ergonovine—HTR1E—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00665	0.00826	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00663	0.00823	CbGpPWpGaD
Ergonovine—Bromocriptine—DRD2—Gilles de la Tourette syndrome	0.00652	0.0491	CrCbGaD
Ergonovine—Pergolide—HTR2A—Gilles de la Tourette syndrome	0.00626	0.0471	CrCbGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00617	0.00767	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00585	0.00726	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00568	0.00705	CbGpPWpGaD
Ergonovine—Lisuride—HTR2A—Gilles de la Tourette syndrome	0.00544	0.0409	CrCbGaD
Ergonovine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00529	0.0852	CbGeAlD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00529	0.00657	CbGpPWpGaD
Ergonovine—Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.00522	0.0393	CrCbGaD
Ergonovine—Bromocriptine—HTR2A—Gilles de la Tourette syndrome	0.00504	0.0379	CrCbGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00445	0.00553	CbGpPWpGaD
Ergonovine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00435	0.07	CbGeAlD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00432	0.00537	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00432	0.00537	CbGpPWpGaD
Ergonovine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00419	0.0674	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00403	0.005	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0037	0.0046	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00343	0.00426	CbGpPWpGaD
Ergonovine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00338	0.0543	CbGeAlD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00333	0.00414	CbGpPWpGaD
Ergonovine—HTR2C—brain—Gilles de la Tourette syndrome	0.00333	0.0535	CbGeAlD
Ergonovine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00325	0.0523	CbGeAlD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0031	0.00386	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00294	0.00365	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00292	0.00363	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00286	0.00355	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00283	0.00352	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00282	0.0035	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00281	0.00349	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00266	0.0033	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00264	0.00328	CbGpPWpGaD
Ergonovine—ADRA1A—brain—Gilles de la Tourette syndrome	0.00258	0.0415	CbGeAlD
Ergonovine—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00252	0.00313	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00252	0.00313	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0025	0.00311	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00244	0.00303	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00243	0.00302	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00239	0.00297	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00229	0.00284	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00228	0.00283	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00226	0.00281	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00224	0.00278	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00222	0.00276	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00217	0.0027	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00217	0.0027	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00214	0.00266	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00207	0.00257	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00203	0.00252	CbGpPWpGaD
Ergonovine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00202	0.0325	CbGeAlD
Ergonovine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00195	0.0313	CbGeAlD
Ergonovine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0019	0.00237	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00186	0.00231	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00185	0.0023	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00185	0.0023	CbGpPWpGaD
Ergonovine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00174	0.028	CbGeAlD
Ergonovine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00172	0.00214	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00159	0.00198	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00158	0.00197	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00145	0.0018	CbGpPWpGaD
Ergonovine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00143	0.023	CbGeAlD
Ergonovine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00176	CbGpPWpGaD
Ergonovine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00138	0.0222	CbGeAlD
Ergonovine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00135	0.00168	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00131	0.00163	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00127	0.00157	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00123	0.00153	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00122	0.00152	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00121	0.0015	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00117	0.00146	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00115	0.00143	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00114	0.00142	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00112	0.00139	CbGpPWpGaD
Ergonovine—ABCB1—brain—Gilles de la Tourette syndrome	0.00109	0.0176	CbGeAlD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00108	0.00134	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00104	0.0013	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00104	0.00129	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000977	0.00121	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000973	0.00121	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000949	0.00118	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000884	0.0011	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000872	0.00108	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000855	0.00106	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000802	0.000996	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000728	0.000904	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000723	0.000898	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000682	0.000847	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000679	0.000844	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000659	0.000819	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000619	0.000769	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000614	0.000763	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000577	0.000717	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000561	0.000696	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000522	0.000649	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00043	0.000534	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000366	0.000454	CbGpPWpGaD
